A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure

2013334 citationsJournal Articlehybrid Open Access

Authors

Xinli Li

Jian Zhang

Jun Huang

Aiqun Ma · First Affiliated Hospital of Xi'an Jiaotong University

Jiefu Yang · Beijing Hospital

Weimin Li · Harbin Medical University

Zonggui Wu · Shanghai Changzheng Hospital

Chen Yao · Peking University

Abstract

On a background of standard treatment, qili qiangxin capsules further reduced the levels of NT-proBNP. Together, our data suggest that qili qiangxin capsules could be used in combination therapy for CHF.

Topics & Keywords

Heart Rate Variability and Autonomic Control Traditional Chinese Medicine Studies Healthcare and Venom Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the American College of Cardiology

Volume 62, Issue 12, pp. 1065-1072

DOI: 10.1016/j.jacc.2013.05.035

Field-Weighted Citation Impact: 9.71